Method Validation [Bioanalytics]

posted by Loky do – Egypt, 2025-03-13 12:19 (97 d 16:09 ago) – Posting: # 24386
Views: 2,220

Dears
Appreciate your advice
What are the potential implications of mistakenly designing the QC high at 70% of the upper limit and analyzing study samples based on this? Would re-validation and reanalysis of all samples be required, or could this deviation be accepted by regulatory authorities?

Thanks in Advance
LD

Complete thread:

UA Flag
Activity
 Admin contact
23,424 posts in 4,927 threads, 1,674 registered users;
44 visitors (0 registered, 44 guests [including 7 identified bots]).
Forum time: 05:28 CEST (Europe/Vienna)

Philosophy, like medicine, has plenty of drugs, few good remedies,
and hardly any specific cures.    Sebastien-Roch Nicolas de Chamfort

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5